Metraipolis › archive › dc_a7e671e14540

Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869177
DOI
10.7759/cureus.103754
License (as archived)
solo-consultazione
Archived
2026-11-05T17:38:54.559Z
SHA-256 of the archived text
37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc
Stable URL of this page
https://metraipolis.com/documento/dc_a7e671e14540

How to cite

Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177 — Europe PMC (en), https://europepmc.org/article/MED/41869177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7e671e14540 (Metraipolis archive dc_a7e671e14540, sha256 37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc)
BibTeX
@misc{dca7e671e14540,
  title = {Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7e671e14540; sha256 37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869177. Agents can read the archived copy with the MCP tool read_document.